Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating brentuximab vedotin with combination chemotherapy in older adults with previously untreated stage II-IV Hodgkin lym…
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma [Phase 2]
Phase 2 trial update evaluating combination chemotherapy with or without radiation therapy in favorable-risk Hodgkin Lymphoma among young pa…
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: Treatment With Nivolumab at the Fixed Dose 40 mg (Nivo40) in Patients With Relapsed/Refractory Hodgkins Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating fixed-dose nivolumab (40 mg) in relapsed/refractory Hodgkin lymphoma completed.
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: Camrelizumab(SHR-1210) Combined With GEMOX in Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial investigating camrelizumab (SHR-1210) plus GEMOX in relapsed or refractory Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT [Phase 1]
Phase 1 trial exploring a calcineurin inhibitor-free graft-versus-host disease prevention regimen after related haploidentical peripheral bl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-20Clinical Trial Update: Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating total-body irradiation and fludarabine phosphate followed by donor peripheral blood stem cell transpla…
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease [Phase 2]
Phase 2 trial of high-dose gemcitabine, busulfan, and melphalan for patients with refractory Hodgkin's lymphoma completed.
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant [Phase 2]
Phase 2 trial investigating sirolimus, cyclosporine, and mycophenolate mofetil to prevent graft-versus-host disease in patients with blood c…
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies [Phase 2]
Phase 2 clinical trial assessing donor atorvastatin to prevent severe acute GVHD after nonmyeloablative peripheral blood stem cell transplan…
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: OPTmizing Advanced Stage HodgkIn LymphoMa patIentS Therapy [Phase 2]
A Phase 2 clinical trial update for OPTmizing Advanced Stage Hodgkin Lymphoma Therapy is listed, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2019-11-14Clinical Trial Update: Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 trial of atezolizumab in relapsed or refractory Hodgkin lymphoma was terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: Everolimus in Combination With DHAP in Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating Everolimus in combination with DHAP for relapsed or refractory Hodgkin Lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: A Phase 2 Multi-Center Study of Entinostat (SNDX-275) in Patient With Relapsed or Refractory Hodgkin's Lymphoma [Phase 2]
Phase 2 multi-center trial of entinostat (SNDX-275) in relapsed or refractory Hodgkin's lymphoma; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Clinical trial investigating lenalidomide and temsirolimus in relapsed or refractory Hodgkin lymphoma and non-Hodgkin lymphoma across Phase …
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating bone marrow transplantation from fully matched relatives as donors for hematologic malignancies has completed; resu…
-
CLINICAL_TRIALS trial_result · 2019-10-11Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update on donor umbilical cord blood transplant for hematologic cancers; status completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 1, Phase 2]
Clinical trial evaluating Brentuximab Vedotin with Gemcitabine for younger patients with relapsed or refractory Hodgkin lymphoma completed, …
-
CLINICAL_TRIALS trial_result · 2019-08-05Clinical Trial Update: Molecular and Whole-body MR Imaging in Lymphomas [NA]
Completed clinical trial investigating molecular and whole-body MRI imaging methods in lymphoma patients; results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: Clinical Efficacy of MOAP Regimen for Relapsed/Refractory cHL as a Rescue Therapy After DP Regimen [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating MOAP regimen as rescue therapy for relapsed/refractory Hodgkin lymphoma after DP regimen.
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 clinical trial evaluating autologous peripheral blood stem cell transplant followed by donor bone marrow transplant in high-risk B- …
-
CLINICAL_TRIALS trial_result · 2019-05-06Clinical Trial Update: Brentuximab Vedotin (Recombinant) for IV Infusion - Special Drug Use Surveillance (All-case Surveillance) "Relapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell Lymphoma"
Clinical trial update for brentuximab vedotin (Recombinant) in relapsed or refractory CD30+ Hodgkin's lymphoma or anaplastic large cell lymp…
-
CLINICAL_TRIALS trial_result · 2019-04-02Clinical Trial Update: Clinical Application of Polyethylene Glycol Liposome Doxorubicin (PLD) in Primary Lymphoma [Phase 4]
Phase 4 clinical trial update evaluating polyethylene glycol liposome doxorubicin (PLD) for primary lymphoma (including Non-Hodgkin and Hodg…
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: SHR-1210 Alone or in Combination With Decitabine in Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating SHR-1210 alone or with decitabine in relapsed or refractory Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2019-03-27Clinical Trial Update: Autologous and Allogeneic Transplant for Relapsed Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial update on autologous and allogeneic transplant for relapsed lymphoma, completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas [Phase 2]
Phase 2 trial update of cellular immunotherapy targeting EBV in viral-induced cancers including various lymphomas; the study is terminated w…